Clinical Trial Update: Effects of DL-3-n-butylphthalide on Chemotherapy-Induced Cognitive Impairment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of DL-3-n-butylphthalide on chemotherapy-induced cognitive impairment. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Cognitive Impairment

Drugs mentioned

• DL-3-n-butylphthalide (DL-3-n-butylphthalide)

Snippet

Sponsor: First Hospital of China Medical University | Conditions: Chemotherapy-Related Cognitive Impairment, DL-3-n-butylphthalide | Phase 4 | Status: NOT_YET_RECRUITING